At a glance
- Originator Aventis
- Class Antivirals; Triterpenes
- Mechanism of Action HIV envelope protein gp120 inhibitors; HIV envelope protein gp41 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 06 Oct 1994 Discontinued-Preclinical for HIV infections treatment in France (Unknown route)